WebApr 6, 2024 · CPRX Stock Overview. About the company. Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine … WebFind real-time CPRX - Catalyst Pharmaceuticals Inc stock quotes, ... Financials. Next reporting date: May 9, 2024: EPS forecast (this quarter) $0.32: Annual revenue (last …
Crypto Perx (CPRX) Price, Charts, and News - Coinbase
WebCPRX Catalyst Pharmaceuticals Inc. Annual Income Statement - WSJ Subscribe Sign In Catalyst Pharmaceuticals Inc. CPRX (U.S.: Nasdaq) View All companies AT CLOSE … WebFinancials: CPRX Edit my quotes Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours CPRX CPRX … bobby golson
CPRX Catalyst Pharmaceuticals Inc. Quarterly Balance Sheet
WebFinancials: CPRX Edit my quotes Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours … WebApr 6, 2024 · CPRX Catalyst Pharmaceuticals, Inc. Financial Income Statement 17.73K followers $17.38 0.45 ( +2.66%) 4:00 PM 04/06/23 NASDAQ $USD Post-Market: $17.43 +0.05 (+0.29%) 7:59 PM Summary... WebJan 23, 2024 · Analysts following CPRX stock expect a repeat performance from the December quarter. They call for 48% sales growth to $56.8 million, according to FactSet. But a lower-cost generic would eat into ... clinics in nassau bahamas